Pharmafile Logo
Pharmafocus logo
Advanced Search

Contract research news in brief

March 27, 2012
Research and Development AMRI, Cetero, Kforce, Particle Sciences and QED Clinical Services, inVentiv Health

Cetero files for bankruptcy after FDA admonishments, AMRI shutters Hungarian facility and inVentiv Health buys Kforce; also updates from Particle …

News

UK government launches new dementia programme

March 26, 2012
Medical Communications, Sales and Marketing Alzheimer's, Cameron, UK, dementia

The government has signalled its intention to boost dementia funding and awareness with its new ‘challenge on dementia’ campaign.  In …

News

Mobile monitoring of asthma ‘no better’ than traditional methods

March 26, 2012
Medical Communications BMJ, Mobile monitoring, apps, asthma, smartphone

Mobile phone monitoring of asthma is ‘more expensive and no better than paper monitoring’, says new research.  Findings published in …

News

HPI strengthens healthcare and pharma presence with new hire

March 26, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

HPI has strengthened its presence in the healthcare and pharma sectors with the appointment of Marianne MacDonell. She will head …

Appointment

UCB nominates new board members

March 26, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing UCB, board members

UCB has nominated Harriet Edelman and Charles-Antoine Janssen to become new members of UCB’s board of directors. The new nominations …

Appointment
NICE hq pic

NICE looking into unlicensed and off-label drug use

March 26, 2012
Sales and Marketing DoH, NICE, off label, off-label, postcode, unlicensed

NICE is reviewing the use of off-label and unlicensed medicines across the NHS in England. This follows a pilot project …

News

Rare diseases – pharma’s new frontier

March 26, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, CAPS, McConaghie, rare diseases

The last ten years has seen our understanding of rare diseases move ahead rapidly, often thanks to greater understanding of …

Feature
Shire image

Shire signs CNS disorders deal with Heptares

March 23, 2012
Research and Development A2A, CNS, GPCR, Heptares, Shire

Shire is to develop and commercialise a novel adenosine A2A antagonist discovered by Heptares currently in pre-clinical development.UK-based Heptares discovers and …

News

High Court rules against Seroquel XR patent

March 23, 2012
Sales and Marketing Accord, AstraZeneca, Sandoz, Seroquel, Teva

A British High Court has ruled that AstraZeneca’s patent on its new formulation of the antipsychotic Seroquel is invalid. Seroquel …

News

Zaicom appoints Dr Beverly Barr as its new director

March 23, 2012
Business Services, Medical Communications, Sales and Marketing Beverly Barr, Zaicom

Zaicom International has appointed Dr Beverly Barr as its new director and board member. The UK-based med comms group said …

Appointment

Early-stage research gains another funding boost

March 23, 2012
Research and Development, Sales and Marketing GSK, Index Ventures, Janssen, R&D

GlaxoSmithKline and Janssen are among the key investors in a venture capital fund aimed solely at identifying promising pharma start-ups.  …

News

Universal World Events Celebrates Business Wins

March 22, 2012
Sales and Marketing

Universal WorldEvents is delighted to announce a number of recent business development successes in the first two months of 2012. The …

News
Press release
NICE image

NICE starts new wave of quality standards

March 22, 2012
Sales and Marketing Commissioning Board, Future Forum, NHS, NICE

NICE has been given 123 new quality standards to work on, and includes for the first time new standards for …

News
screen_shot_2012-03-22_at_11

Working Life: Mike Crooks, UK general manager, Astellas

March 22, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas Pharma, Mike Crooks, Working Life

 Mike Crooks became general manager of Astellas Pharma in December 2011. He joined Astellas in 2007 as marketing director, becoming …

Feature
GSK image

GSK selects Ulverston for biopharma manufacturing hub

March 22, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Cameron, GSK, Ulverston, manufacturing

GlaxoSmithKline has announced the long-awaited decision on the location of its biopharmaceutical plant in the UK, with Ulverston in Cumbria …

News

NHS faces 10 years of savings, say managers

March 22, 2012
Sales and Marketing NHS, QIPP, Stout, reforms, think tank

The NHS will have to make £40 billion in savings by 2020, meaning budgets will be tighter for longer.  The …

News

Former Roche man Guido Magni joins Versant

March 22, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Versant, appointment, investment firm

Dr Guido Magni is joining US-based firm Versant Ventures as a venture partner to further strengthen the firm’s investment team …

Appointment
Abbott image

Abbott selects ‘AbbVie’ as new name for R&D firm

March 21, 2012
Research and Development, Sales and Marketing Abbott

Abbott has said its new R&D firm will be called AbbVie, and expects to launch the spin-off company at the …

News

Lundbeck appoints new vice president of business development

March 21, 2012
Sales and Marketing

Lundbeck has appointed Jacob Tolstrup as its new vice president with responsibility for the company’s business development. Along with his …

Appointment

Life sciences to benefit from new UK budget plans

March 21, 2012
Sales and Marketing ABPI, BIA, Budget, life sciences, tax

The UK life sciences industry will benefit from a cut in corporation tax and additional funding for academic research. The …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026